Literature DB >> 10528034

A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

S J Silverberg1, E Shane, T P Jacobs, E Siris, J P Bilezikian.   

Abstract

BACKGROUND AND METHODS: In the United States, most patients with primary hyperparathyroidism have few or no symptoms. The need for parathyroidectomy to treat all patients with this disorder has therefore been questioned. We studied the clinical course and development of complications for periods of up to 10 years in 121 patients with primary hyperparathyroidism, 101 (83 percent) of whom were asymptomatic. There were 30 men and 91 women (age range, 20 to 79 years). During the study, 61 patients (50 percent) underwent parathyroidectomy, and 60 patients were followed without surgery.
RESULTS: Parathyroidectomy in patients with or without symptoms led to normalization of serum calcium concentrations and a mean (+/-SE) increase in lumbar-spine bone mineral density of 8+/-2 percent after 1 year (P=0.005) and 12+/-3 percent after 10 years (P=0.03). Bone mineral density of the femoral neck increased 6+/-1 percent after 1 year (P=0.002) and 14+/-4 percent after 10 years (P=0.002). Bone mineral density of the radius did not change significantly. The 52 asymptomatic patients who did not undergo surgery had no change in serum calcium concentration, urinary calcium excretion, or bone mineral density. However, 14 of these 52 patients (27 percent) had progression of disease, defined as the development of at least one new indication for parathyroidectomy. All 20 patients with symptoms had kidney stones. None of the 12 who underwent parathyroidectomy had recurrent kidney stones, whereas 6 of the 8 patients who did not undergo surgery did have a recurrence.
CONCLUSIONS: In patients with primary hyperparathyroidism, parathyroidectomy results in the normalization of biochemical values and increased bone mineral density. Most asymptomatic patients who did not undergo surgery did not have progression of disease, but approximately one quarter of them did have some progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528034     DOI: 10.1056/NEJM199910213411701

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  162 in total

Review 1.  Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?

Authors:  D S Rao
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

Review 2.  Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?

Authors:  J Rastad
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

Review 3.  Asymptomatic hyperparathyroidism: is the pendulum swinging back?

Authors:  K Siminoski
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

Review 4.  Pathogenesis of postmenopausal osteoporosis.

Authors:  L G Raisz
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 5.  Clinical spectrum of primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

6.  Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism.

Authors:  M D Walker; T Rundek; S Homma; M DiTullio; S Iwata; J A Lee; J Choi; R Liu; C Zhang; D J McMahon; R L Sacco; S J Silverberg
Journal:  Eur J Endocrinol       Date:  2012-06-01       Impact factor: 6.664

Review 7.  Primary hyperparathyroidism: pathophysiology and impact on bone.

Authors:  A Khan; J Bilezikian
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

8.  Potential utility of high preoperative levels of serum type I collagen markers in postmenopausal women with primary hyperparathyroidism with respect to their short-term variations after parathyroidectomy.

Authors:  Philippe Boudou; Fidaa Ibrahim; Catherine Cormier; Emile Sarfati; Jean-Claude Souberbielle
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

9.  Predictors of renal function in primary hyperparathyroidism.

Authors:  Marcella D Walker; Thomas Nickolas; Anna Kepley; James A Lee; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

10.  Brown jaw tumors: today's unusual presentation of primary hyperparathyroidism.

Authors:  S Corbetta; D Rossi; O D'Orto; L Vicentini; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.